ATE183546T1 - Tumorspezifischer monoklonaler antikörper 81av78 - Google Patents

Tumorspezifischer monoklonaler antikörper 81av78

Info

Publication number
ATE183546T1
ATE183546T1 AT92913154T AT92913154T ATE183546T1 AT E183546 T1 ATE183546 T1 AT E183546T1 AT 92913154 T AT92913154 T AT 92913154T AT 92913154 T AT92913154 T AT 92913154T AT E183546 T1 ATE183546 T1 AT E183546T1
Authority
AT
Austria
Prior art keywords
tumor
monoclonal antibody
specific monoclonal
monoclonal antibodies
therapy
Prior art date
Application number
AT92913154T
Other languages
English (en)
Inventor
Michael G Hanna Jr
Martin V Haspel
Herbert C Hoover Jr
Original Assignee
Perimmune Holdings Inc
Michael G Hanna Jr
Martin V Haspel
Herbert C Hoover Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perimmune Holdings Inc, Michael G Hanna Jr, Martin V Haspel, Herbert C Hoover Jr filed Critical Perimmune Holdings Inc
Application granted granted Critical
Publication of ATE183546T1 publication Critical patent/ATE183546T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT92913154T 1991-05-16 1992-05-14 Tumorspezifischer monoklonaler antikörper 81av78 ATE183546T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70128191A 1991-05-16 1991-05-16

Publications (1)

Publication Number Publication Date
ATE183546T1 true ATE183546T1 (de) 1999-09-15

Family

ID=24816733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92913154T ATE183546T1 (de) 1991-05-16 1992-05-14 Tumorspezifischer monoklonaler antikörper 81av78

Country Status (8)

Country Link
EP (1) EP0584267B1 (de)
JP (1) JPH06508028A (de)
AT (1) ATE183546T1 (de)
AU (1) AU656785B2 (de)
CA (1) CA2108767A1 (de)
DE (1) DE69229829D1 (de)
FI (1) FI935038A0 (de)
WO (1) WO1992020785A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828991A (en) * 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use

Also Published As

Publication number Publication date
DE69229829D1 (de) 1999-09-23
AU656785B2 (en) 1995-02-16
FI935038A (fi) 1993-11-15
CA2108767A1 (en) 1992-11-17
WO1992020785A1 (en) 1992-11-26
EP0584267A4 (de) 1994-11-02
EP0584267B1 (de) 1999-08-18
AU2029892A (en) 1992-12-30
FI935038A0 (fi) 1993-11-15
JPH06508028A (ja) 1994-09-14
EP0584267A1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
ATE71410T1 (de) Tumorspezifische monoklonale antikoerper.
ATE233102T1 (de) Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
NZ512722A (en) Use of Ep-CAM antibodies for anticancer vaccination
DE69229829D1 (de) Tumorspezifischer monoklonaler antikörper 81av78
DE68924983T2 (de) Anti-idiotyp antikörper induktion eines antitumorenresponses.
IL86958A (en) Human monoclonal antibody igm 16-88, cell lines producing it and antigen recognized thereby
FI924576A0 (fi) Ctaa 28a32, antigen identiefierad av mca 28a32
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
Triozzi et al. Clinical and immunologic effects of monoclonal antibody CC49 and interleukin-2 in patients with metastatic colorectal cancer
Hellström et al. Mouse Bladder Carcinoma as a Model to Study Immune Manipulations in Man
Fagerberg The idiotypic network response in cancer patients treated with monoclonal antibodies.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties